Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine

• Published in: Cephalalgia Vol. 39; no. 12; pp. 1569 - 1576
• Main Authors: Doty, Erin Gautier, Krege, John H, Jin, Leah, Raskin, Joel, Halker Singh, Rashmi B, Kalidas, Kavita
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.10.2019
• Subjects: Original; migraine; pain freedom; Lasmiditan; pain relief; sustained response

Background Sustained pain freedom is an important attribute of acute migraine therapies for patients and physicians. Here we report efficacy of the centrally penetrant, highly selective, 5-HT1F agonist lasmiditan on sustained pain freedom and other outcomes at 24 and 48 hours post-dose. Study design...